Critical Assessment of In Vitro Screening of α-Glucosidase Inhibitors from Plants with Acarbose as a Reference Standard
- 18 October 2021
- journal article
- review article
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 88 (12) , 1078-1091
Abstract
Postprandial hyperglycemia is treated with the oral antidiabetic drug acarbose, an intestinal α-glucosidase inhibitor. Side effects of acarbose motivated a growing number of screening studies to identify novel α-glucosidase inhibitors derived from plant extracts and other natural sources. As “gold standard”, acarbose is frequently included as the reference standard to assess the potency of these candidate α-glucosidase inhibitors, with many outperforming acarbose by several orders of magnitude. The results are subsequently used to identify suitable compounds/products with strong potential for in vivo efficacy. However, most α-glucosidase inhibitor screening studies use enzyme preparations obtained from nonmammalian sources (typically Saccharomyces cerevisiae), despite strong evidence that inhibition data obtained using nonmammalian α-glucosidase may hold limited value in terms of identifying α-glucosidase inhibitors with actual in vivo hypoglycemic potential. The aim was to critically discuss the screening of novel α-glucosidase inhibitors from plant sources, emphasizing inconsistencies and pitfalls, specifically where acarbose was included as the reference standard. An assessment of the available literature emphasized the cruciality of stating the biological source of α-glucosidase in such screening studies to allow for unambiguous and rational interpretation of the data. The review also highlights the lack of a universally adopted screening assay for novel α-glucosidase inhibitors and the commercial availability of a standardized preparation of mammalian α-glucosidase.Keywords
Funding Information
- Department of Science and Innovation, South Africa (DST/CON 0023/2015)
- Universiteit Stellenbosch (Consolidoc Postdoctoral Grant to N. Miller)
This publication has 144 references indexed in Scilit:
- Protective Nature of Mangiferin on Oxidative Stress and Antioxidant Status in Tissues of Streptozotocin-Induced Diabetic RatsISRN Pharmacology, 2013
- In vitro and in vivo effects of standardized extract and fractions of Phaleria macrocarpa fruits pericarp on lead carbohydrate digesting enzymesBMC Complementary and Alternative Medicine, 2013
- Screening of-Glucosidase Inhibitory Activity from Some Plants of Apocynaceae, Clusiaceae, Euphorbiaceae, and RubiaceaeJournal of Biomedicine and Biotechnology, 2012
- Mini-Special Issue paper Management of diabetic patients with hypoglycemic agents α-Glucosidase inhibitors and their use in clinical practiceArchives of Medical Science, 2012
- α-glucosidase inhibitors from plants: A natural approach to treat diabetesPharmacognosy Reviews, 2011
- Antioxidant rich grape pomace extract suppresses postprandial hyperglycemia in diabetic mice by specifically inhibiting alpha-glucosidaseNutrition & Metabolism, 2010
- α-Glucosidase inhibitory activity of Syzygium cumini (Linn.) Skeels seed kernel in vitro and in Goto–Kakizaki (GK) ratsCarbohydrate Research, 2008
- Salacia oblonga improves cardiac fibrosis and inhibits postprandial hyperglycemia in obese zucker ratsLife Sciences, 2004
- The structure of human pancreaticα-amylase at 1.8 Å resolution and comparisons with related enzymesProtein Science, 1995
- Nutritional Recommendations for Diabetic Patients and Treatment with α-Glucosidase InhibitorsDrugs, 1992